Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1/2a Study of Umbilical Cord Lining Stem Cells (ULSC) in Patients With ARDS Due to COVID-19

NCT04494386 is registered in ClinicalTrials.gov with Restem, LLC. as lead sponsor.

NCT NCT04494386
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04494386 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1/2a Study of Umbilical Cord Lining Stem Cells (ULSC) in Patients With ARDS Due to COVID-19
Lead sponsor
Restem, LLC.
Phase
Phase 1/2
Overall status
Completed
Start date
December 23, 2020
Completion date
May 12, 2023
Enrollment
17 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

ards, corona virus infection, coronavirus, covid19, sars-cov infection